117 results
Page 5 of 6
8-K
EX-10.1
qhs2ky
24 Nov 20
Entry into a Material Definitive Agreement
6:07am
424B5
d0k5cda332fz7hi
24 Nov 20
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
305mquvt18 yj5f
9 Nov 20
Baudax Bio Reports Third Quarter 2020 Financial Results
7:10am
8-K
EX-99.1
d5ruk9elud33n
9 Nov 20
Baudax Bio Reports Third Quarter 2020 Financial Results
7:10am
8-K
EX-99.1
wog2f 111f
20 Oct 20
Baudax Bio Provides Commercial and Corporate Update
7:30am
8-K
EX-99.1
592p9q4b
22 Sep 20
Other Events
7:00am
8-K
EX-99.1
wrupz7
10 Aug 20
Baudax Bio Reports Second Quarter 2020 Financial Results
7:01am
8-K
EX-99.2
0fgs8l78
10 Aug 20
Baudax Bio Reports Second Quarter 2020 Financial Results
7:01am
8-K
EX-99.1
i48qygw8nr7l l5
20 Jul 20
Other Events
7:40am
8-K
EX-99.1
rxrp63
15 Jun 20
Baudax Bio Announces Full Commercial Launch of ANJESO™ and Receipt of UniqueC-Code and Pass-Through Payment Status
8:37am
8-K
EX-10.1
zki9g264o9p502p
2 Jun 20
Entry into a Material Definitive Agreement
7:45am
8-K
EX-99.1
ajuaqav96t73fllxay
8 May 20
Baudax Bio Reports First Quarter 2020 Financial Results
7:52am
424B5
qyj ymq76f0uccdtp61
24 Mar 20
Prospectus supplement for primary offering
5:04pm
424B5
i05o5ptkx 01y0u5fc
23 Mar 20
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
h5x81ah
21 Feb 20
Other Events
9:27am
8-K
EX-99.1
vg62kdfp y1e44
20 Feb 20
Regulation FD Disclosure
5:29pm